Results of these studies will enable a deeper understanding of leptin physiology and possible therapeutic applications as well as prevention of obesity and metabolic disease associated with leptin and leptin receptor heterozygosity or partial leptin deficiency. The gene discussed is LEPR; the disease is metabolic disease.